Onconova Therapeutics, Inc (NASDAQ: ONTX) closed at $0.28 this Tuesday. This suggests that the company made a negative move of -1.59% from its previous day stock price.
ONTX stocks have a beta value of 2.02. Previous day’s low was $0.2733 and the high was $0.2845. The 52-week trailing price-to-earnings ratio stands at 0. On a 12-monthly basis, the high stands at $1.56 and the low at $0.1. Within the last 30 days, ONTX stocks have made a considerable gain of -12.09%.
Analysts Makes Estimate Of NASDAQ: ONTX Earnings
NASDAQ: ONTX will reportedly announce its report on the quarterly earnings on 12th August. During the release time, ONTX investors were worried about a loss even before the release as the company’s forward dividend was 0 and the yield was 0%.
Analysts estimated that NASDAQ: ONTX will post $0.03 as EPS for the quarter, $0.13 as yearly EPS for 2020 and $0.14 as yearly EPS for 2021. This suggests that ONTX stocks are headed for a 0.91% and 0.08% growth for 2020 and 2021 respectively.
Onconova Therapeutics, Inc. On “Hold” Rating Consensus
However, short-term and medium-term investors have recently assigned an obvious “Sell” rating to this stock. However, long-term investors are still hoping for a bigger upside potential of ONTX stocks and have assigned a 50% “Sell” status to ONTX stocks.
Four analysts have submitted reports on the company’s ratings till now. All four of them have rated ONTX stocks as “Hold”. No one has rated it as Buy or underperform or sell.
Thus, the recent consensus regarding Onconova Therapeutics, Inc. stands at the “hold” rating Several hedge funds and institutional investors are taking advantage of the current metrics. They have also been involved in buying and selling of NASDAQ: ONTX shares recently.
To further delve into ONTX stock metrics, we can say that the company’s PEG ratio is 0. The current ONTX price level stands at 3.1% from the 200-day simple moving average and about 34.41% off its 50-day simple moving average. The 30-days volatility rate is 9.8% and 7-days volatility rate is 1098%. The beta value of the company’s stocks is 2.02 along with an ATR of 0.03.
Onconova Therapeutics, Inc. (NASDAQ: ONTX) has a trading volume of 21.76 million for an average of three months. The past 10-day trading volume of the company is 14.45 million. The company’s current outstanding shares stand at 183.58 million.
About 11% of ONTX stocks are held by institutions while insiders hold only about 0.91%. The company trades at short-interest of about 13.22 million that makes the short-interest ratio about 0.53. These metrics make NASDAQ: ONTX a hot stock right now as the upside potential of the stock looks great.